Work

The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent

Year: 2008

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of the American College of Cardiology

DOI: 10.1016/j.jacc.2007.11.079

Authors: Emile R. Mohler, Christie M. Ballantyne, Michael H. Davidson, Markolf Hanefeld, Luis M. Ruilope, Joel L. Johnson, Andrew Zalewski

Institutions: University of Pennsylvania, Baylor College of Medicine, Rush University Medical Center, Technische Universität Dresden, Hospital Universitario 12 De Octubre, GlaxoSmithKline (United States), Thomas Jefferson University

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: GlaxoSmithKline

OpenAlex ID: W1586079541

FWCI: 27.78

Cites: 46

Cited by: 209

Related to: 10